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Background:  Little data exist on perioperative management and outcomes amongst PCI patients receiving dual antiplatelet therapy and oral 
anticoagulation (triple therapy [TT]) who undergo non-cardiac surgery.
methods:  We identified post-PCI VA patients undergoing surgery between 2004-2011, and collected their antiplatelet and anticoagulation 
prescription status and perioperative medication management. We measured the prevalence and association between TT, MACCE and bleeding in the 
30d after surgery compared to those not on TT, after adjusting for relevant clinical factors.
results:  Between 2004-2011, 21,475 post-PCI VA patients underwent surgery. Of these, 391 (1.8%) were on TT. TT patients were more likely to 
have atrial fibrillation, DM, CHF, CVD, HTN, prior GI bleeding, and higher rCRI and CHADS-2 scores. Patients on TT were more likely to suffer MACCE 
(OR 1.7, CI 1.2-2.4), but not RBC transfusion (OR 1.4, CI 1.0-1.9) or bleeding (OR 1.3, CI 0.9-1.8) (Figure 1). Among patients receiving TT, aspirin, 
clopidogrel, and coumadin were held for ≥1 day prior to surgery in 52%, 38%, and 51% respectively. In patients with held aspirin, TT was associated 
with higher MACCE and bleeding rates compared to non-TT patients. In contrast, there was no relationship between TT, MACCE, and bleeding in 
patients with held coumadin or clopidogrel.
conclusions:  1.8% of post-PCI VA patients undergoing surgery are on TT. Relative to those not on TT, they are more likely to suffer MACCE but not 
bleeding events after surgery.
 
